Cancer cells evade the host’s immunity by inhibiting immune effector cells, particularly cytotoxic (CD8+) T cells, by employing immune checkpoint pathways, such as programmed cell death-1 (PD-1) and cytotoxic T-lymphocyte antigen-4 (CTLA-4). The gene discussed is PDCD1; the disease is cancer.